GSGabriela Bianchi dos Santos

Gabriela Bianchi dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriela Bianchi dos Santos has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sustainable nanotechnology-based approach for the valorization of Amazonian Carapa guianensis seed oil in dermocosmetic formulations

    by Bruna Carvalho Cantal de Souza, Brenda Campos Uchôa, Cristiane dos Santos Giuberti, Maurília de Oliveira Souza, Rodrigo Rezende Kitagawa, Rodrigo de Almeida Romagna, Ester da Silva Tonini, Kariane Mendes Nunes, Adenilson de Sousa Barroso, Rosa Helena Veras Mourão, et al.


  • Discovering Macrolide SmTGR Inhibitors via QSAR and Molecular Docking for Schistosomiasis Repurposing

    by Sabrina Silva-Mendonça, José T. Moreira-Filho, Steven U. S. Hall, Carolina H. Andrade, Gabriela B. dos Santos

    Macrolides, a class of broad-spectrum antibiotics, are gaining attention for their potential in treating parasitic infections due to their favorable safety profiles, pharmacokinetics, and tissue penetration. This study explores the possibility of repurposing macrolides for the treatment of schistosomiasis, a neglected tropical disease caused by the trematode Schistosoma mansoni. Using computational approaches and molecular docking, including quantitative structureactivity relationship (QSAR) models, we evaluated the predicted binding affinities and inhibition probabilities of macrolides against S. mansoni thioredoxin glutathione reductase (SmTGR), a key enzyme in the parasite redox balance. The virtual screening identified eight promising macrolides, with Sorangicin A emerging as a promising hit compound due to its strong predicted interactions with SmTGR. The results suggest that Sorangicin A and other macrolides may exhibit potential antischistosomal activity, highlighting their viability as repurposed therapeutics. This study underscores the value of leveraging established drug classes for new applications, particularly in addressing neglected diseases. Combining QSAR and molecular docking, we demonstrate a cost- and time-efficient strategy for identifying novel treatments. It is offered a pathway to combat schistosomiasis and other parasitic infections, which must be validated experimentally.

  • Open Access

    Essential Oil of Lippia origanoides Kunth: Nanoformulation, Anticholinesterase Activity, and Molecular Docking

    by Antônio Quaresma da Silva Júnior, Gabriela dos Santos Rodrigues, Adenilson de Sousa Barroso, Pablo Luis Baia Figueiredo, Francisco Paiva Machado, Mikaela Amaral Ferreira, Caio Pinho Fernandes, Gabriela B. dos Santos, Rosa Helena V. Mourão

    This study investigates the therapeutic potential of Lippia origanoides essential oil (LOEO) in neurological and pharmaceutical applications. The chemical composition of LOEO was analyzed using gas chromatography–mass spectrometry (GC-MS), revealing major constituents, such as carvacrol, thymol, and γ-gurjunene, known for their antioxidant and antimicrobial properties. LOEO demonstrated significant acetylcholinesterase (AChE)-inhibitory activity, particularly in a nanoformulation that enhances bioavailability and stability. Additionally, the major constituent carvacrol, when tested in isolation, also exhibited AChE-inhibitory activity comparable to that of the nanoformulation. Molecular docking analysis indicated strong binding affinities between LOEO compounds and AChE, supporting its therapeutic potential for neurodegenerative diseases like Alzheimer’s. Additionally, in silico pharmacokinetic predictions revealed favorable absorption and blood–brain barrier penetration profiles for key constituents. Despite promising results, this study acknowledges the need for in vivo validation and long-term stability assessments of the nanoformulation. Future research should focus on pharmacodynamic studies and evaluating the oil’s effectiveness in animal models. These findings highlight LOEO as a valuable candidate for developing natural therapies for neurodegenerative diseases.


  • Open Access

    Anxiolytic, Antidepressant, and Anticholinesterase Effects of Essential Oil from Myrcia sylvatica (G.Mey.) DC

    by Antônio Quaresma da Silva Júnior, Mariana Maciel Garcia, Wanderson da Silva Farias, Deise Juliane dos Anjos de Sousa, Adenilson de Sousa Barroso, Pablo Luis Baia Figueiredo, Gabriela B. dos Santos, Ricardo Bezerra de Oliveira, Rosa Helena Veras Mourão

    Aromatic plants are rich sources of essential oils (EOs), recognized for their therapeutic properties due to their diversity of phytochemicals. This study investigated the anxiolytic and antidepressant effects of Myrcia sylvatica essential oil (MsEO) through inhalation in an animal model and its in vitro anticholinesterase (AChE) activity. The EO was obtained by hydrodistillation, and its volatile constituents were analyzed by GC-MS. Swiss mice were exposed to doses of 0.1%, 1%, and 2% of the EO via an inhalation apparatus. The anxiolytic activity was assessed using the elevated plus maze and light–dark box tests, while antidepressant activity was evaluated using the tail suspension and forced swimming tests. To examine potential side effects, the animals were subjected to rotarod, Y-maze, and Morris water maze tests to assess motor coordination, memory, and learning. Anticholinesterase activity was determined by direct bioautography and colorimetry based on the Ellman method. The results demonstrated that inhalation of MsEO at doses of 0.1% and 1% significantly reduced anxiety and depressive-like behaviors without impairing memory, learning, or motor coordination in the animals. Moreover, MsEO inhibited acetylcholinesterase with an IC50 of 0.47 μg/mL. These findings suggest that MsEO has potential therapeutic applications for anxiety and depression disorders, with additional anticholinesterase activity warranting further investigation in cognitive-related conditions.


  • Open Access

    Development of a liquid crystalline gel based on Amazonian butter extracted from ucuúba seeds (Virola surinamensis (Rol. ex Robbt.) Warb.) for vaginosis treatment

    by Amanda Carolline Esquerdo da Silva, Gabriela Bianchi dos Santos, Edilene Gadelha de Oliveira, Kariane Mendes Nunes

    This study focuses on developing a liquid crystalline gel based on ucuúba butter from the Amazon. This gel, which offers distinct technological advantages for vaginal sustained drug release systems, was characterized by polarized light microscopy (PLM), pH measurements, water uptake assay, drug release profile and kinetic study (using the Excel Add-in and DDSolver). The unloaded and drug-loaded liquid crystalline gel containing 10% metronidazole exhibited a hexagonal mesophase structurally favorable for sustained drug release, with a pH value of 6,4 ± 0.024. The water uptake profile showed a fast water uptake in up to 1 h, approximately 16%, with the maximum amount of water, 40%, in 8 h. After water uptake, the liquid crystalline gel undergoes self-assembly to a viscous cubic phase, avoiding rapid erosion in an aqueous medium. In vitro, the release of metronidazole was slow, with 52% of the drug released in 10 h. The best fit was the Higuchi kinetic model with the highest MSC (3,94) and R2 (0,98) values, indicating that the drug release was diffusion-controlled. Korsmeyer’s model showed that formulation exhibited anomalous transport (non-Fickian). Given the limited number of options for topical vaginal treatment, this liquid crystalline gel based on Virola surinamensis (Rol. ex Robbt.) Warb.) butter could potentially find applicability to reduce the frequency of administration and improve local concentrations of metronidazole on vaginal mucous.

  • Open Access

    Mapeamento Tecnológico sobre o Uso de Banco de Dados Aplicados à Produção de Cosméticos Capilares Personalizados

    by Azauri dos Santos Figueira, Carla Marina Costa Paxiuba, Gabriela Bianchi dos Santos

    Diversos cosméticos capilares disponíveis no mercado apresentam compostos tóxicos e geralmente não consideram as características individuais do usuário. Assim, este estudo propôs-se a mapear tecnologias fundamentadas no uso de banco de dados destinadas à personalização de cosméticos capilares produzidos a partir de compostos naturais sem a presença de agentes tóxicos. Para tanto, foram selecionadas bases tecnológicas (©Questel Orbit e INPI) e bases científicas (Scopus, ScienceDirect e Web of Science). Foram incluídos no estudo patentes e artigos científicos sobre produtos capilares de origem vegetal, livres de agentes tóxicos, e personalizados a partir de tecnologias fundamentadas no uso de banco de dados. Dessa forma, a amostra foi composta de 11 patentes e 18 artigos. Os resultados destacam a República da Coreia como país que recebe maior número de pedidos de patentes, e a L’Oréal como empresa depositante. Considerando a gravidade dos efeitos dos agentes tóxicos, a abordagem desse tema mostra-se pertinente.

  • Open Access

    Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains

    by Lana P. S. Oliveira, Lúcio R. Lima, Luciane B. Silva, Jorddy N. Cruz, Ryan S. Ramos, Luciana S. Lima, Francy M. N. Cardoso, Aderaldo V. Silva, Dália P. Rodrigues, Gabriela S. Rodrigues, et al.

    Staphylococcus aureus is a microorganism with high morbidity and mortality due to antibiotic-resistant strains, making the search for new therapeutic options urgent. In this context, computational drug design can facilitate the drug discovery process, optimizing time and resources. In this work, computational methods involving ligand- and structure-based virtual screening were employed to identify potential antibacterial agents against the S. aureus MRSA and VRSA strains. To achieve this goal, tetrahydroxybenzofuran, a promising antibacterial agent according to in vitro tests described in the literature, was adopted as the pivotal molecule and derivative molecules were considered to generate a pharmacophore model, which was used to perform virtual screening on the Pharmit platform. Through this result, twenty-four molecules were selected from the MolPort® database. Using the Tanimoto Index on the BindingDB web server, it was possible to select eighteen molecules with greater structural similarity in relation to commercial antibiotics (methicillin and oxacillin). Predictions of toxicological and pharmacokinetic properties (ADME/Tox) using the eighteen most similar molecules, showed that only three exhibited desired properties (LB255, LB320 and LB415). In the molecular docking study, the promising molecules LB255, LB320 and LB415 showed significant values in both molecular targets. LB320 presented better binding affinity to MRSA (−8.18 kcal/mol) and VRSA (−8.01 kcal/mol) targets. Through PASS web server, the three molecules, specially LB320, showed potential for antibacterial activity. Synthetic accessibility (SA) analysis performed on AMBIT and SwissADME web servers showed that LB255 and LB415 can be considered difficult to synthesize and LB320 is considered easy. In conclusion, the results suggest that these ligands, particularly LB320, may bind strongly to the studied targets and may have appropriate ADME/Tox properties in experimental studies.


  • Open Access

    Mapeamento de Tecnologias Direcionadas à Prevenção de Lesão por Pressão Alinhadas às Diretrizes Internacionais

    by Paulo Henrique Santos Coelho, Rosinei de Sousa Oliveira, Gabriela Bianchi dos Santos

    Uma lesão por pressão é um dano na pele ou no tecido subjacente ocasionado pela pressão em excesso. Neste estudo, objetivou-se o mapeamento de tecnologias profiláticas em conformidade com a Diretriz Internacional de Prevenção e Tratamento de Lesão por Pressão. Para isso, a metodologia seguiu as etapas da prospecção e, por meio de quatro bases de dados (PubMed, Scopus, Web of Science e Questel Orbit), foram feitas buscas por documentos situados entre os anos de 2009 e 2021. Entre as bases científicas, foram selecionados 45 artigos por meio dos quais se constatou um predomínio do uso de curativos profiláticos. Na base Questel Orbit, foram selecionadas 29 patentes, nas quais se verificou um volume considerável de tecnologias relacionadas à suspensão do calcanhar. Neste estudo, a China foi o país que demonstrou as menores taxas de ocorrência da lesão, o que fortalece a importância de seguir as recomendações da diretriz.


  • Wound Healing Activity of Topical Formulations Containing Mauritia flexuosa Oil

    by Carlena S. M. da Silva, Junior A. de Araújo, Tiago S. Silveira, Kelly C. F. Castro, Leopoldo C. Baratto, Renata C. K. Kaminski, Gabriela B. Santos, Kariane M. Nunes


  • In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity

    by João Marcos Galúcio, Elton Figueira Monteiro, Deivid Almeida de Jesus, Clauber Henrique Costa, Raissa Caroline Siqueira, Gabriela Bianchi dos Santos, Jerônimo Lameira, Kauê Santana da Costa